Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12


A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan.

Chi H, Hsu CH, Chang JH, Chiu NC, Hung HY, Kao HA, Weng LC, Huang FY, Chiu YY, Chang LY, Huang LM.

PLoS One. 2014 Jun 27;9(6):e100981. doi: 10.1371/journal.pone.0100981. eCollection 2014.


Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy.

Hiatt A, Bohorova N, Bohorov O, Goodman C, Kim D, Pauly MH, Velasco J, Whaley KJ, Piedra PA, Gilbert BE, Zeitlin L.

Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):5992-7. doi: 10.1073/pnas.1402458111. Epub 2014 Apr 7.


Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study.

Blanken MO, Koffijberg H, Nibbelke EE, Rovers MM, Bont L; Dutch RSV Neonatal Network.

PLoS One. 2013;8(3):e59161. doi: 10.1371/journal.pone.0059161. Epub 2013 Mar 12.


Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children.

Ramos GF, Kuiper S, Dompeling E, van Asselt AD, de Grauw WJ, Knottnerus JA, van Schayck OC, Schermer TR, Severens JL.

BMC Med Res Methodol. 2011 Nov 9;11:150. doi: 10.1186/1471-2288-11-150.


Impact of respiratory syncytial virus: the nurse's perspective.

Bracht M, Basevitz D, Cranis M, Paulley R.

Drugs R D. 2011 Sep 1;11(3):215-26. doi: 10.2165/11593140-000000000-00000. Review.


A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice.

Paes BA, Mitchell I, Banerji A, Lanctôt KL, Langley JM.

Can Respir J. 2011 Mar-Apr;18(2):e10-9.


Prevention of respiratory syncytial virus infection.

Samson L.

Paediatr Child Health. 2009 Oct;14(8):521-32. English, French.


Palivizumab for the prevention of respiratory syncytial virus infection.

Rogovik AL, Carleton B, Solimano A, Goldman RD.

Can Fam Physician. 2010 Aug;56(8):769-72.


Association of IL-13 in respiratory syncytial virus-induced pulmonary disease: still a promising target.

Mukherjee S, Lukacs NW.

Expert Rev Anti Infect Ther. 2010 Jun;8(6):617-21. doi: 10.1586/eri.10.39. No abstract available.


Impact of palivizumab on RSV hospitalizations for children with hemodynamically significant congenital heart disease.

Chang RK, Chen AY.

Pediatr Cardiol. 2010 Jan;31(1):90-5. doi: 10.1007/s00246-009-9577-0. Epub 2009 Nov 14.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk